Skip to content
HeyJared

Michael Erman

Reporter · AU

Indexed articles, last 90 days
1
Latest publication
Aug 19, 2026
Outlet visibility, for Brisbane Times
Top 100K sites
Earliest in this view
Aug 19, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest articles

  1. Article · Aug 19, 2026 · Michael Erman, Julie Steenhuysen

    ‘Landmark’: New mRNA vaccine could prevent skin cancer from returning, companies say (opens the original)

    Excerpt · Positive tone · English

    Read excerpt

    New York: Moderna and Merck said a personalised mRNA cancer vaccine reduced the risk of recurrence and spread of melanoma in a late-stage trial, a major success in a new field of cancer treatment that sent Moderna’s shares surging more than 170 per cent. The companies tested the vaccine together with Merck’s immunotherapy drug Keytruda, a widely used melanoma treatment. Thousands of patients who have undergone surgery to remove high-risk melanoma tumours could benefit as soon as next year if reg

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 100K sites

For Brisbane Times, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Michael Erman